2 Reasons the Market Frowned After AbbVie's Blowout Q2 -- and 1 Reason It Should Be Excited

2 Reasons the Market Frowned After AbbVie's Blowout Q2 -- and 1 Reason It Should Be Excited

Source: 
Motley Fool
snippet: 

AbbVie (NYSE:ABBV) did it again. The big drugmaker posted fantastic numbers in its first-quarter results reported in April. AbbVie announced more great results with its second-quarter earnings update on Friday.